Circulating TIMP-1 is associated with hematoma volume in patients with spontaneous intracranial hemorrhage

Manuel Navarro-Oviedo1, Roberto Muñoz-Arrondo2, Beatriz Zandio2

  • 1Laboratory of Atherothrombosis, CIMA, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, IdisNA, Pamplona, Spain.

Scientific Reports
|June 27, 2020
PubMed

Insights

Tissue inhibitors of matrix metalloproteinases (TIMPs) show potential as biomarkers for intracranial hemorrhage (ICH). TIMP-1 levels correlate with hematoma volume, and its administration may offer therapeutic benefits in ICH cases.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Clinical Medicine

Background:

  • Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play roles in tissue remodeling and are implicated in various pathologies.
  • Intracranial hemorrhage (ICH) is a critical condition with significant morbidity and mortality, necessitating improved diagnostic and therapeutic tools.

Purpose of the Study:

  • To investigate the potential of MMPs and TIMPs as clinical biomarkers for spontaneous non-traumatic ICH.
  • To explore the relationship between plasma levels of specific MMPs and TIMP-1 with clinical, radiological, and functional outcomes in ICH patients.
  • To evaluate the effect of TIMP-1 administration on bleeding in an experimental model.

Main Methods:

  • Recruitment of 29 patients from Complejo Hospitalario de Navarra (CHN) and 76 from Vall d´Hebron (VdH) with spontaneous non-traumatic ICH.
  • Measurement of plasma levels of MMP-1, -2, -7, -9, -10, and TIMP-1.
  • Correlation analysis between biomarker levels and clinical, radiological (hematoma volume), and functional variables.
  • Experimental study of TIMP-1 (0.05-0.2 mg/Kg) in a mouse tail-bleeding model.

Main Results:

  • In CHN, TIMP-1 correlated with admission-hematoma volume, and MMP-7 was higher in deep ICH compared to lobar ICH.
  • In VdH, admission-hematoma volume was associated with TIMP-1 and MMP-7.
  • Combined analysis showed a significant association between TIMP-1 levels and hematoma volume (β = 0.14, p < 0.05).
  • Mice treated with TIMP-1 (0.2 mg/Kg) exhibited significantly reduced bleeding times (p < 0.01).

Conclusions:

  • The consistent association of TIMP-1 with hematoma volume in two independent ICH cohorts highlights its potential as a valuable biomarker for ICH.
  • Elevated TIMP-1 may not fully counteract MMP upregulation in ICH, suggesting that TIMP-1 administration could be a promising therapeutic strategy to mitigate bleeding.

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...